Results 161 to 170 of about 31,625 (241)

Pathogenesis of Relapsing Fever. [PDF]

Curr Issues Mol Biol, 2021
Lopez J, Hovius JW, Bergström S.
europepmc   +1 more source

Mycoplasma pneumoniae‐Induced Rash and Mucositis: Clinicopathologic Characterization of 11 Cases

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Mycoplasma pneumoniae‐induced rash and mucositis (MIRM) is a mucocutaneous eruption affecting children and young adults with respiratory tract or clinically occult infection by M. pneumoniae. Mucosal involvement is often robust and may raise concern for Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).
Margaret Lang Houser, Jennifer B. Mancuso, Johann E. Gudjonsson, Alexandra C. Hristov, Lori Lowe, May P. Chan   +5 more
wiley   +1 more source

Public Health Aspects of an Outbreak of Tick Relapsing Fever in Non-Europeans in Kimberley.

, 1944
D Ordman
openalex   +1 more source

A case of true relapse in enteric fever

, 1885
John W. Moore
openalex   +2 more sources

Relapsing Fever Outbreak Investigation in Bahir-Dar, Amhara Region, Ethiopia [PDF]

, 2014
Addisu Workineh Kassa
openalex   +1 more source

Correction: Head Lice of Pygmies Reveal the Presence of Relapsing Fever Borreliae in the Republic of Congo. [PDF]

PLoS Negl Trop Dis
PLOS Neglected Tropical Diseases Editors.
europepmc   +1 more source

Analysis of variable major protein antigenic variation in the relapsing fever spirochete, Borrelia miyamotoi, in response to polyclonal antibody selection pressure. [PDF]

PLoS One, 2023
Gilmore RD, Armstrong BA, Brandt KS, Van Gundy TJ, Hojgaard A, Lopez JE, Kneubehl AR.   +6 more
europepmc   +1 more source

An Evidence Based Rationale for Making Tick - borne Relapsing Fever a Nationally Notifiable Disease

, 2019
Kyle M Hatcher
openalex   +1 more source

Immunological and Molecular Analyses of the Borrelia hermsii Factor H and Factor H-Like Protein 1 Binding Protein, FhbA: Demonstration of Its Utility as a Diagnostic Marker and Epidemiological Tool for Tick-Borne Relapsing Fever

, 2006
Kelley M. Hovis, Martin E. Schriefer, Sonia Bahlani, Richard T. Marconi   +3 more
openalex   +1 more source

Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30‐positive cutaneous T‐cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce.
Patrick Schummer, Caroline Glatzel, Philipp Schrüfer, Ingulf Lawrenz, Gabor Dobos, Ulrike Wehkamp, Svea Hüning, René Stranzenbach, Jan P. Nicolay, Matthias Goebeler, Marion Wobser   +10 more
wiley   +1 more source